And now … for the truly paranoid …

… a research letter in this week’s issue of JAMA Internal Medicine has real implications for anyone who spends significant time in a hospital … as a patient, as a healthcare professional, or just as someone visiting a patient. … READ MORE …

What are the very best hospitals for cancer care in America doing that is “better”?

According to a new article in JAMA Oncology, just published on line yesterday, we may be able to better define which really are “the best” hospitals in America at which cancer care (prostate cancer care specifically included) is being given today. … READ MORE …

Hospital volume important to outcomes among older, sicker, Medicare patients treated by RP

A media release issued by Henry Ford Health System earlier today has a distinctly misleading headline that reads as follows: “Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery.” You need to read the content of the media release with care to understand that this headline is by no means an accurate summation of the results of the study referred. … READ MORE …

Are clinical benefits of RALP being over-hyped to unsuspecting prostate cancer patients?

Back in March, a group of authors from three major medical centers published a report in the Journal for Healthcare Quality strongly suggesting that U.S. hospitals were inappropriately over-promoting the  use of robot-assisted surgery for treatment of prostate cancer. … READ MORE …

Prostate cancer news reports: Friday, June 12, 2009

Todays news reports adddress:

  • Surgeon and hospital volume and outcomes to radical prostatectomy
  • Adverse events associated with the use of hypofractionated, dose-escalated, IMRT
  • Quality of sexual function after external beam radiation therapy
  • Percentage of positive biopsy cores and response to first-line hormone therapy … READ MORE …

The prostate cancer news for Thursday, July 30

News items today are focused on information about:

  • a new way of approaching treatment of hormone-refractory disease
  • the initial clinical trials of a new drug candidate in hormone-refractory patients
  • the association between hospital and surgeon volume and patient outcomes after radical prostatectomy. … MORE …